Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Wondering who needs long term care insurance at 55? Learn about the key factors that determine your need for coverage.
27,171 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
When a memory-stock rally hits the headlines, you want the real story behind the move. This guide explains why sandis...
Kyntra Bio (KYNB) is on investors' radar as 2025 earnings wrap up. This guide breaks down what the Q4 results mean, h...
As AI chip fears rattled markets, microsoft stock rose today thanks to cloud momentum, AI software adoption, and stro...
The Trade Desk slid again amid reports of agency cautions and analyst downgrades. This piece explains the drivers, wh...
Prices stay higher than a few years ago, eroding cash savings. A trio of ETFs—GLD, VTIP, and DBC—are positioned to he...
When market swings unsettle investors, reliable dividend stocks double right can stabilize returns. Here are two prov...
Starting with $100? Learn how to choose the best growth index invest in March 2026. This practical guide compares low...
Berkshire Hathaway has been selling some positions, but a single airline stock remains a headline-grabber. This artic...
Thinking ahead to 2026? This guide explains why a Vanguard index fund before the next big move can fit a simple, disc...
A sudden price jump can grab headlines and wallets. This guide explains why stock soared today, how to verify the dri...
After years of headwinds, Target is showing early signs of life. Yet the stock price tells a story of cautious optimi...